Program

Friday
May 10th, 2019
09:00
Opening
09:15 - 09:45
Opening Lecture:
Eliano Pio Navarese (Bydgoszcz, Poland)
Aspirin is still the mainstay antithrombotic treatment? The answer is YES.
09:45 - 11:15
Session I
Chairpersons: Miłosz Jaguszewski, Adam Sukiennik
09:45 - 10:05
Andrzej Kleinrok (Zamość, Poland)
In-hospital and long term mortality rate of patients hospitalized due to heart failure decompensation.
10:05 - 10:25
Piotr Jankowski (Kraków, Poland)
Arterial stiffness, aortic pulse pressure and coronary artery disease.
10:25 - 10:45
Wojciech Wojakowski (Katowice, Poland)
Antiplatelet treatment after structural interventions (TAVI, LAA, MitraCLiP, PVL).
10:45 - 11:15
Discussion
11:15 - 11:30
Coffee break
11:30 - 13:00
Session II
Chairpersons: Piotr Jankowski, Wojciech Wojakowski
11:30 - 11:45
Jakub Ratajczak (Bydgoszcz, Poland)
Mild therapeutic hypothermia trial - cliniacal outcome. The UNICORN study.
11:45 - 11:55
Małgorzata Ostrowska (Bydgoszcz, Poland)
The EMERALD trial
11:55 - 12:05
Małgorzata Jasiewicz (Bydgoszcz, Poland)
The ENTRESTO trial
12:05 - 12:15
Michalina Kołodziejczak (Bydgoszcz, Poland)
The PREDATOR trial
12:15 - 12:30
Jacek Kubica (Bydgoszcz, Poland)
Levosimendan in critically ill patients with ACS. The LEONARDO project
12:30 - 13:00
Discussion
14:00 - 15:40
COPERNICUS AWARD SESSION
10 presentations (10 best reports among all posters) - competition for young investigators <30 years of age.
13:00 - 14:00
Lunch
15:40 - 16:00
Coffee break
16:00 - 17:50
Session III
Chairpersons: Jacek Kubica, Eliano Pio Navarese
16:00 - 16:20
Bernd Jilma (Vienna, Austria)
Platelet inhibition in critically ill patients
16:20 - 16:40
Miłosz Jaguszewski (Gdańsk, Poland)
Macrophagic enhancement in optical coherence tomography imaging by means of superparamagnetic iron oxide nanoparticles.
16:40 - 17:00
Diana Gorog (London, UK)
Endogenous fibrinolysis: a novel predictor of cardiovascular risk.
17:00 - 17:20
Adam Sukiennik (Bydgoszcz, Poland)
Resorbable magnezium scaffold in calcified coronary lesions trial: overview and study design
17:20 - 17:50
Discussion
19:00
Dinner
Saturday
May 11th, 2019
08:30 - 10:00
Session IV
Chairpersons: Bernd Jilma, Tomasz Zdrojewski
08:30 - 08:50
Bogumił Ramotowski (Warszawa, Poland)
Effect of smoking cessation on the pharmacokinetics and pharmacodynamics of clopidogrel after PCI: The smoking cessation paradox study.
08:50 - 09:10
Klemen Steblovnik (Lubljana, Slovenia)
Antiplatelet treatment in patients after out-of-hospital cardiac arrest undergoing therapeutic hypothermia.
09:10 - 09:30
Piotr Niezgoda (Bydgoszcz, Poland)
How to overcome the morphine effect in ACS patients?
09:30 - 10:00
Discussion
10:00 - 10:15
Coffee break
10:15 - 11:45
Session V
Chairpersons: Wojciech Drygas, Klemen Steblovnik
10:15 - 10:35
Karolina Obońska (Bydgoszcz, Poland)
The effectiveness of hypercholesterolemia treatment with rosuvastatin combined with ezetimibe - The RosEze study.
10:35 - 10:55
Izabella Uchmanowicz (Wrocław, Poland)
Frailty as a cardiovascular risk factor
10:55 - 11:15
Tomasz Zdrojewski (Gdańsk, Poland)
Acute Myocardial Infarction in Poland - what changes can we expect within 10-20 years
11:15 - 11:45
Discussion
11:45 - 12:00
Coffee break
12:00 - 13:30
Session VI
Chairpersons: Bogumił Ramotowski, Izabella Uchmanowicz
12:00 - 12:20
Witold Śmigielski (Warszawa, Poland)
Longevity and cardiovascular mortality in elite Polish football players
12:20 - 12:40
Robert Gajda (Warszawa, Poland)
Health profile of champion ultramarathon runner. Changes in biochemical, hematological and cardiac parameters following 24 h run at Polish Championship
12:40 - 13:00
Wojciech Drygas (Warszawa, Poland)
Changes in biochemical, hematological and cardiac parameters following strenuous ultraendurance swimming
13:00 - 13:30
Discussion